Personalis, Inc. (PSNL) reporting calendar
Personalis, Inc. files periodic reports with the SEC as PSNL on Nasdaq. Atlas tracks 28 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 26 Jul 2026 – 17 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 28
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open PSNL market profile
Latest filing on SEC EDGAR ↗
Services-Medical Laboratories reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-211896 |
| 10-K | 31 Dec 2025 | 26 Feb 2026 | 57 days | 0001193125-26-076615 |
| 10-Q | 30 Sep 2025 | 4 Nov 2025 | 35 days | 0001193125-25-264708 |
| 10-Q | 30 Jun 2025 | 5 Aug 2025 | 36 days | 0000950170-25-102993 |
| 10-Q | 31 Mar 2025 | 6 May 2025 | 36 days | 0000950170-25-064512 |
| 10-K | 31 Dec 2024 | 27 Feb 2025 | 58 days | 0000950170-25-029221 |
| 10-Q | 30 Sep 2024 | 6 Nov 2024 | 37 days | 0000950170-24-122290 |
| 10-Q | 30 Jun 2024 | 7 Aug 2024 | 38 days | 0000950170-24-092883 |
| 10-Q | 31 Mar 2024 | 8 May 2024 | 38 days | 0000950170-24-055607 |
| 10-K | 31 Dec 2023 | 28 Feb 2024 | 59 days | 0000950170-24-022097 |
| 10-Q | 30 Sep 2023 | 7 Nov 2023 | 38 days | 0000950170-23-060255 |
| 10-Q | 30 Jun 2023 | 8 Aug 2023 | 39 days | 0000950170-23-039799 |
| 10-Q | 31 Mar 2023 | 3 May 2023 | 33 days | 0000950170-23-017182 |
| 10-K | 31 Dec 2022 | 23 Feb 2023 | 54 days | 0000950170-23-004139 |
| 10-Q | 30 Sep 2022 | 2 Nov 2022 | 33 days | 0000950170-22-021272 |
| 10-Q | 30 Jun 2022 | 3 Aug 2022 | 34 days | 0001564590-22-027773 |
| 10-Q | 31 Mar 2022 | 4 May 2022 | 34 days | 0001564590-22-017858 |
| 10-K | 31 Dec 2021 | 24 Feb 2022 | 55 days | 0001564590-22-006722 |
| 10-Q | 30 Sep 2021 | 4 Nov 2021 | 35 days | 0001564590-21-054262 |
| 10-Q | 30 Jun 2021 | 4 Aug 2021 | 35 days | 0001564590-21-040831 |
| 10-Q | 31 Mar 2021 | 5 May 2021 | 35 days | 0001564590-21-024077 |
| 10-K | 31 Dec 2020 | 25 Feb 2021 | 56 days | 0001564590-21-008848 |
| 10-Q | 30 Sep 2020 | 5 Nov 2020 | 36 days | 0001564590-20-051319 |
| 10-Q | 30 Jun 2020 | 6 Aug 2020 | 37 days | 0001564590-20-037746 |
| 10-Q | 31 Mar 2020 | 7 May 2020 | 37 days | 0001564590-20-022986 |
| 10-K | 31 Dec 2019 | 25 Mar 2020 | 85 days | 0001564590-20-012826 |
| 10-Q | 30 Sep 2019 | 13 Nov 2019 | 44 days | 0001564590-19-043238 |
| 10-Q | 30 Jun 2019 | 13 Aug 2019 | 44 days | 0001564590-19-031814 |
Source: SEC EDGAR company submissions for CIK 0001527753. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.